Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression
Bone mineral density; Calcium; Fracture; Meta-regression; Vitamin D
Abstract :
[en] Surrogate measures of fracture risk, such as effects on bone mineral density, may be of great interest to assess the efficacy of available osteoporosis treatments. Our results suggest that bone mineral density (BMD) changes cannot be used as a surrogate of anti-fracture efficacy, among patients receiving calcium, with or without vitamin D.
Introduction: The purpose of this study is to examine the association between changes in bone mineral density with reduction in the risk of fractures in patients receiving calcium with or without vitamin D.
Methods: We selected all randomized placebo-controlled clinical trials of calcium with or without vitamin D supplementation. To be included in this analysis, the studies were required to report both BMD (hip/proximal femur and/or lumbar spine) and the incidence of fractures. Metaregression analyses were used to examine the associations of changes in BMD with reduction in risk of fracture over the duration of each study. The change in BMD was the difference between changes (from baseline) observed in the active treatment group and placebo group.
Results: A total of 15 randomized trials (n=47,365) were identified, most of whom (77%) came from the Women’s Health Initiative trial. Results show that larger increases in BMD at the lumbar spine were not associated with greater reduction in fracture risk. Concerning hip BMD changes, we found a statistically significant relationship between hip BMD changes and reduction in risk. However, results were not quite significant after excluding the both largest studies, in which BMD changes were measured in very small subset of patients. These points may have largely biased our results.
Conclusions: In conclusion, there was no evidence of a relationship between BMD changes and reduction in risk of fractures among patients receiving calcium with or without vitamin D supplementation. Calcium and/or Vitamin D may reduce fracture rates through a mechanism independent of bone density.
Disciplines :
Endocrinology, metabolism & nutrition Public health, health care sciences & services
Author, co-author :
Rabenda, Véronique ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression
Publication date :
2011
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Temple RJ (1995) A regulatory authority's opinion about surrogate endpoints. In: Nimmo WS, Tucker GT (eds) Clinical measurement in drug evaluation. Wiley, New York
Z Li AA Chines MP Meredith 2004 Statistical validation of surrogate endpoints: is bone density a valid surrogate for fracture? J Musculoskelet Neuron Interact 4 6474
ML Bouxsein PD Delmas 2008 Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective J Bone Miner Res 23 1155 1167 10.1359/jbmr.080301 18318643 (Pubitemid 352040171)
S Boonen JJ Body Y Boutsen JP Devogelaer S Goemaere JM Kaufman S Rozenberg JY Reginster 2005 Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club Osteoporos Int 16 239 254 10.1007/s00198-004-1812-1 15726235 (Pubitemid 40379423)
R Rizzoli S Boonen ML Brandi N Burlet P Delmas JY Reginster 2008 The role of calcium and vitamin D in the management of osteoporosis Bone 42 246 249 1:CAS:528:DC%2BD1cXls1eiuw%3D%3D 10.1016/j.bone.2007.10.005 18055288
BM Tang GD Eslick C Nowson C Smith A Bensoussan 2007 Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis Lancet 370 657 666 1:CAS:528:DC%2BD2sXpsFWrsbc%3D 10.1016/S0140-6736(07)61342-7 17720017 (Pubitemid 47285316)
AR Jadad RA Moore D Carroll C Jenkinson 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 12 1:STN:280:DyaK28zgvVCmug%3D%3D 10.1016/0197-2456(95)00134-4 8721797 (Pubitemid 26120810)
CB Begg M Mazumdar 1994 Operating characteristics of a rank correlation test for publication bias Biometrics 50 1088 1101 1:STN:280:DyaK2Mzgs1GrtQ%3D%3D 10.2307/2533446 7786990
M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple graphical test BMJ 315 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D 9310563 (Pubitemid 27387172)
R Hatal S Keitz P Wyer G Guyatt on behalf of the Evidence-Based Medicine Teaching Tips Working Group 2005 Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results CMAJ 172 661 665 (Pubitemid 40342102)
IR Reid RW Ames MC Evans GD Gamble SJ Sharpe 1993 Effect of calcium supplementation on bone loss in postmenopausal women N Engl J Med 328 7 460 464 1:CAS:528:DyaK3sXltFKjtbs%3D 10.1056/NEJM199302183280702 8421475 (Pubitemid 23056435)
T Chevalley R Rizzoli V Nydegger D Slosman CH Rapin JP Michel H Vasey JP Bonjour 1994 Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients Osteoporos Int 4 245 252 1:STN:280:DyaK2M7htFaisQ%3D%3D 10.1007/BF01623348 7812072 (Pubitemid 24291432)
BL Riggs WM O'Fallon J Muhs MK O'Connor R Kumar LJ Melton 3rd 1998 Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women J Bone Miner Res 13 168 174 1:CAS:528:DyaK1cXhtlSlsbs%3D 10.1359/jbmr.1998.13.2.168 9495509 (Pubitemid 28082372)
M Peacock G Liu M Carey R McClintock W Ambrosius S Hui CC Johnston 2000 Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60 J Clin Endocrinol Metab 85 3011 3019 1:CAS:528:DC%2BD3cXmsVKrtbk%3D 10.1210/jc.85.9.3011 10999778
T Fujita M Ohue Y Fujii A Miyauchi Y Takagi 2004 Reappraisal of Katsuragi calcium study, a prospective, double-blind, placebo-controlled study of the effect of active absorbable algal calcium (AAACa) on vertebral deformity and fracture J Bone Miner Metab 22 1 32 38 1:CAS:528:DC%2BD3sXhtVSjsb3N 10.1007/s00774-003-0445-3 14691684 (Pubitemid 38140040)
IR Reid B Mason A Horne R Ames HE Reid U Bava MJ Bolland GD Gamble 2006 Randomized controlled trial of calcium in healthy older women Am J Med 119 777 785 1:CAS:528:DC%2BD28XptlyrsL4%3D 10.1016/j.amjmed.2006.02.038 16945613 (Pubitemid 44291631)
RL Prince A Devine SS Dhaliwal IM Dick 2006 Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women Arch Intern Med 166 869 875 1:CAS:528:DC%2BD28XkslensrY%3D 10.1001/archinte.166.8.869 16636212
IR Reid R Ames B Mason HE Reid CJ Bacon MJ Bolland GD Gamble A Grey A Horne 2008 Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men Arch Intern Med 168 20 2276 2282 1:CAS:528: DC%2BD1cXhsVKjtL7M 10.1001/archinte.168.20.2276 19001206
MC Chapuy ME Arlot F Duboeuf J Brun B Crouzet S Arnaud P Delmas PJ Meunier 1992 Vitamin D3 and calcium to prevent hip fractures in elderly women N Engl J Med 327 1637 1642 1:STN:280:DyaK3s%2FmtlSrug%3D%3D 10.1056/ NEJM199212033272305 1331788
B Dawson-Hughes S Harris E Krall G Dallal 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older N Engl J Med 337 670 676 1:CAS:528:DyaK2sXmt1Wqtbk%3D 10.1056/ NEJM199709043371003 9278463 (Pubitemid 27375473)
MC Chapuy R Pamphile E Paris C Kempf M Schlichting S Arnaud P Garnero PJ Meunier 2002 Combined calcium and vitamin D3 supplementation in elderly women:confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study Osteoporos Int 13 257 264 1:CAS:528: DC%2BD38XksVynt7g%3D 10.1007/s001980200023 11991447 (Pubitemid 34408194)
RH Harwood O Sahota K Gaynor T Masud DJ Hosking 2004 A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: the Nottingham Neck of Femur (NoNOF) Study Age Ageing 33 1 45 51 10.1093/ageing/afh002 (Pubitemid 38111448)
RD Jackson AZ LaCroix M Gass RB Wallace J Robbins CE Lewis Women's Health Initiative Investigators, et al. 2006 Calcium plus vitamin D supplementation and the risk of fractures N Engl J Med 354 669 683 1:CAS:528: DC%2BD28XhsVWksr0%3D 10.1056/NEJMoa055218 16481635 (Pubitemid 43247138)
C Bolton-Smith ME McMurdo CR Paterson PA Mole JM Harvey ST Fenton CJ Prynne GD Mishra MJ Shearer 2007 Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women J Bone Miner Res 22 4 509 519 1:CAS:528:DC%2BD2sXpt1Grtro%3D 10.1359/jbmr.070116 17243866 (Pubitemid 47457427)
K Salovaara M Tuppurainen M Kärkkäinen T Rikkonen L Sandini J Sirola R Honkanen E Alhava H Kröger 2010 Effect of vitamin D3 and calcium on fracture risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial-The OSTPRE-FPS JBMR 25 1487 1495 1:CAS:528:DC%2BC3cXhtFKrtbnJ 10.1002/jbmr.48
S Sarkar BH Mitlak M Wong JL Stock DM Black KD Harper 2002 Relationships between bone mineral density and incident vertebral fractures with raloxifene therapy J Bone Miner Res 17 1 10 1:CAS:528:DC%2BD38XktFyisg%3D%3D 10.1359/jbmr.2002.17.1.1 11771654 (Pubitemid 33150990)
NB Watts C Cooper R Lindsay, et al. 2004 Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk J Clin Densitom 7 255 261 10.1385/JCD:7:3:255 15319494 (Pubitemid 39178892)
Z Li MP Meredith MS Hoseyni 2001 A method to assess the proportion of treatment effect explained by a surrogate endpoint Stat Med 20 3175 3188 1:STN:280:DC%2BD3MnpvVyktg%3D%3D 10.1002/sim.984 11746311 (Pubitemid 33034879)
MC Hochberg PD Ross D Black Fracture Intervention Trial Research Group, et al. 1999 Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis Arthritis Rheum 42 1246 1254 1:CAS:528: DyaK1MXktVegtLo%3D 10.1002/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2- U 10366118 (Pubitemid 29268962)
O Bruyère C Roux J Badurski, et al. 2007 Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate J Clin Endocrinol Metab 23 3076 3081 (Pubitemid 47236373)
RD Wasnich PD Miller 2000 Antifracture efficacy with antiresorptive agents are related to changes in bone density J Clin Endocrinol Metab 85 231 236 1:STN:280:DC%2BD3c%2Fpslymug%3D%3D 10.1210/jc.85.1.231 10634392 (Pubitemid 32268819)
SR Cummings DB Karpf F Harris HK Genant K Ensrud AZ LaCroix DM Black 2002 Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs Am J Med 112 281 289 1:CAS:528:DC%2BD38XhvVWkurk%3D 10.1016/S0002-9343(01)01124-X 11893367 (Pubitemid 34219441)
MC Hochberg S Greenspan RD Wasnich P Miller DE Thompson PD Ross 2002 Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents J Clin Endocrinol Metab 87 1586 1592 1:CAS:528:DC%2BD38XivFKlt7k%3D 10.1210/jc.87.4.1586 11932287 (Pubitemid 34615244)
PD Delmas E Seeman 2004 Changes in bone mineral density explain little of the reduction in vertebral and nonvertebral fracture risk with anti-resorptive therapy Bone 34 599 604 1:CAS:528:DC%2BD2cXisF2ntL4%3D 10.1016/j.bone.2003.12. 022 15050889 (Pubitemid 38393794)
DC Bauer DM Black P Garnero M Hochberg S Ott J Orloff The Fracture Intervention Trial Study Group, et al. 2004 Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial J Bone Miner Res 19 1250 1258 10.1359/JBMR.040512 15231011 (Pubitemid 41094365)
J Compston 2009 Monitoring osteoporosis treatment Best Pract Res Clin Rheumatol 23 781 788 10.1016/j.berh.2009.09.007 19945689
International Society for Clinical Densitometry. Official positions. Available at: www.iscd.org
National Osteoporosis Foundation. New clinicians guide to prevention and treatment of osteoporosis. Available at: www.nof.org
S Thompson J Higgins 2002 How should meta-regression analyses be undertaken and interpreted? Stat Med 21 1559 1573 10.1002/sim.1187 12111920 (Pubitemid 34746063)
P Lambert A Sutton F Abrams, et al. 2002 A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis J Clin Epidemiol 55 86 94 1:STN:280:DC%2BD38%2FlsFymsw%3D%3D 10.1016/S0895-4356(01)00414-0 11781126 (Pubitemid 34037039)
